Galliard wins GSK and Pfizer accounts

November 3, 2005
Medical Communications

Galliard Healthcare Communications has won the global PR account for GlaxoSmithKline's Avodart and been appointed by Pfizer to handle UK …

Tamiflu’s frontline status a mixed blessing for Roche

November 3, 2005
Sales and Marketing

Sales of Roche's Tamiflu have rocketed as governments around the world prepare for a potential pandemic, but its status as …

Waking up to new ways of training

November 3, 2005
Business Services

From sales forecasts to the marketing mix, from business information to regulatory project management, there are as many training courses, …

GSK inspires more confidence than shaky AstraZeneca

November 1, 2005
Research and Development

The UK's two pharma giants have posted strong growth in the third quarter, but investor doubts about AstraZeneca's long-term prospects …

National campaign promotes private healthcare

November 1, 2005
Sales and Marketing

Six of the UK's biggest private hospital and health insurance companies have joined forces to promote the benefits of private …

Tropical disease research centre to open in Liverpool

October 31, 2005
Research and Development

A new UK research centre specialising in the development of new tropical medicines has been given the go-ahead with £18 …

Campaigners dismayed at unworkable partial smoking ban

October 28, 2005
Research and Development

Doctors and health campaigners have expressed their deep disappointment over the government's failure to introduce a complete smoking ban in …

UK patients invited to report side-effects

October 28, 2005
Sales and Marketing

Members of the public will now be able to report adverse events in medicines direct to the UK watchdog through …

Merck and Schering-Plough lifted by cholesterol joint venture

October 26, 2005
Sales and Marketing

A marketing alliance between Merck and Schering-Plough has given the troubled companies some positive news to report.Global sales of the …

Markets shocked by Pfizer sales slump

October 26, 2005
Sales and Marketing

Pfizer, the pharma industry's powerhouse, has suffered a 52% slump in profits in the third quarter, undermining investor confidence in …

Marketing a high priority – but budgets still a battle

October 26, 2005
Sales and Marketing

A survey of marketers across industry sectors has underlined the importance of their role  but shows many have to battle …

Can the NHS become a world-class healthcare system?

October 25, 2005
Sales and Marketing

Tony Blair and Labour were re-elected in May this year for an historic third-term, with the electorate telling pollsters they …

Oxford BioMedica’s lung cancer candidate shows promise

October 25, 2005
Research and Development

A promising antibody developed by UK-based Oxford BioMedica is poised to enter clinical trials to treat lung cancer.The 5T4 antibody-targeted …

Pharma continues to invest in UK research and development

October 24, 2005
Sales and Marketing Pfizer, R&D

 UK pharma and biotech companies increased R&D investment by 4% in the last year, according to the latest government figures.The …

Blockbuster partnerships

October 21, 2005
Research and Development

Since pharma'ps big wave of innovation during the early 1990s, peaking in 1996 when 131 new drug applications were filed …

Vaccine companies to compete for UK pandemic contract

October 20, 2005
Sales and Marketing

Vaccine companies are to compete with each other to produce a vaccine against a potential pandemic flu – although no-one …

New approvals in TNF-blocker class

October 20, 2005
Sales and Marketing

Competition in one of the industry's fastest growing markets is intensifying with new approvals for two TNF-blocker drugs.Schering-Plough and Centocor's …

Resolute wins PR Consultancy of the Year award

October 20, 2005
Medical Communications

Healthcare agency Resolute Communications has been named consultancy of the year at the PRWeek awards, believed to be the first …

Once a day pill promises period-free contraception

October 20, 2005
Sales and Marketing

The world's first-ever contraceptive pill to offer women complete freedom from menstruation could be launched by next year.Wyeth's Lybrel is …

Tarceva/Avastin combination disappoints in kidney cancer

October 19, 2005
Sales and Marketing

Early results from trials suggest adding Tarceva to Avastin has no extra benefit in the treatment of kidney cancer.Researchers at …

The Gateway to Local Adoption Series

Latest content